| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.23 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |